NANTONG CITY,
Mr. Mu has more than twelve years experience in the financial field. Most
recently, Mr. Mu has been an independent consultant working for
''We are greatly pleased to have Mr. Mu join the Company and we are sure
that his professional background and strong management skills will add
tremendous value to Sinobiopharma's future endeavors,'' stated Dr.
Separately, the Company announces that Mr.
''On behalf of the Board of Directors and Sinobiopharma, I want to
personally thank Mr. Shen for his contributions to the Company and wish him
well,'' said Dr.
About Sinobiopharma
Sinobiopharma Inc. is a fully integrated and highly innovative
biopharmaceutical company engaged in the research and development, manufacture
and marketing of biopharmaceutical products in
FORWARD LOOKING STATEMENTS
This news release may include "forward-looking statements" regarding Sinobiopharma, Inc., and its subsidiaries, business and project plans. Such forward looking statements are within the meaning of Section 27A of the Securities Act of 1933, as amended, and section 21E of the United States Securities and Exchange Act of 1934, as amended, and are intended to be covered by the safe harbor created by such sections. Where Sinobiopharma, Inc. expresses or implies an expectation or belief as to future events or results, such expectation or belief is believed to have a reasonable basis. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Sinobiopharma, Inc. does not undertake any obligation to update any forward-looking statement, except as required under applicable law. SOURCE Sinobiopharma, Inc.